Neonc Technologies (NASDAQ:NTHI) Coverage Initiated at Alliance Global Partners

Alliance Global Partners started coverage on shares of Neonc Technologies (NASDAQ:NTHI) in a research report issued on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $13.00 price target on the stock. Alliance Global Partners’ price target would indicate a potential upside of 143.45% from the company’s previous close.

Several other equities research analysts have also issued reports on NTHI. BTIG Research started coverage on shares of Neonc Technologies in a research note on Friday, April 24th. They issued a “buy” rating and a $15.00 price target on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Neonc Technologies in a research note on Friday, March 27th. Finally, Maxim Group started coverage on shares of Neonc Technologies in a research note on Monday. They issued a “buy” rating and a $20.00 price target on the stock. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $16.00.

Neonc Technologies Trading Down 2.9%

Shares of NTHI stock opened at $5.34 on Tuesday. Neonc Technologies has a 1 year low of $3.20 and a 1 year high of $12.99. The firm’s fifty day moving average price is $6.34 and its two-hundred day moving average price is $8.16.

Neonc Technologies (NASDAQ:NTHI) last issued its quarterly earnings results on Monday, May 18th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.16).

Insider Activity at Neonc Technologies

In related news, President Amir F. Heshmatpour bought 10,000 shares of Neonc Technologies stock in a transaction that occurred on Friday, May 1st. The stock was acquired at an average price of $4.16 per share, with a total value of $41,600.00. Following the acquisition, the president owned 3,072,000 shares of the company’s stock, valued at approximately $12,779,520. This represents a 0.33% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders have bought 80,700 shares of company stock worth $423,590.

Institutional Trading of Neonc Technologies

Several hedge funds and other institutional investors have recently modified their holdings of NTHI. Royal Bank of Canada bought a new stake in shares of Neonc Technologies during the 1st quarter worth about $247,000. Bank of America Corp DE bought a new stake in shares of Neonc Technologies during the 2nd quarter worth about $801,000. Foundations Investment Advisors LLC bought a new stake in shares of Neonc Technologies during the 3rd quarter worth about $100,000. HighPoint Advisor Group LLC boosted its holdings in shares of Neonc Technologies by 424.8% during the 3rd quarter. HighPoint Advisor Group LLC now owns 950,232 shares of the company’s stock worth $8,628,000 after buying an additional 769,163 shares during the period. Finally, Vanguard Group Inc. bought a new stake in shares of Neonc Technologies during the 3rd quarter worth about $1,279,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.